Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 89%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
105,265
Total Claims
$32.8M
Drug Cost
2,081
Beneficiaries
$16K
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 21,141 Psychiatry providers
+829%
Cost per patient vs peers
$16K vs $1,696 avg
+229%
Brand preference vs peers
16.3% vs 5.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
ML fraud detection score of 89% indicates prescribing patterns with significant similarity to confirmed fraud cases. 18 out of 20 decision trees flagged this provider.
Cost per patient is 829% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
99
Opioid Claims
$1,284
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 17,141 claims · $26.9M
Generic: 88,028 claims · $5.9M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 846 | $6.6M |
| Deutetrabenazine | 557 | $4.0M |
| Cariprazine Hcl | 2,270 | $2.7M |
| Riluzole | 5,659 | $1.9M |
| Pimavanserin Tartrate | 386 | $1.8M |
| Aripiprazole Lauroxil | 532 | $1.6M |
| Paliperidone Palmitate | 383 | $1.3M |
| Vortioxetine Hydrobromide | 2,904 | $1.2M |
| Deutetrabenazine | 152 | $1.0M |
| Olanzapine/Samidorphan Malate | 509 | $788K |
| Lumateperone Tosylate | 539 | $761K |
| Clozapine | 10,169 | $729K |
| Dextromethorphan Hbr/Quinidine | 544 | $646K |
| Dulaglutide | 669 | $636K |
| Semaglutide | 625 | $634K |
Prescribing Profile
Patient Profile
52
Avg Age
43%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About